← Leaderboards
Michael Allen Brehm
Univ Of Massachusetts Med Sch Worcester
$6,804,033
Attributed
$24,830,711
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,830,711 · 10
By mechanism
R24$8,980,338 · 3
U01$4,515,869 · 1
R01$4,359,670 · 1
UC4$4,109,951 · 1
UG3$1,208,620 · 1
R21$935,990 · 2
Top collaborators
- Leonard D. Shultz21 shared
- Dale L Greiner20 shared
- Rene Maehr10 shared
- George Q Daley6 shared
- Charles P Emerson4 shared
- Sally Choate Kent4 shared
- Jeremy Luban4 shared
- Douglas A Melton4 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Dale L Greiner$17,425,144
- Ann M Moormann$14,521,572
- Jodi Kathleen Maranchie$1,934,209
- Jeremy Luban$28,330,738
- Stephen C. Miller$9,374,213
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoAnimal ModelEngraftmentImmune SystemTissuesMouse ModelHumanized MouseImmuneHuman DiseaseNew TechnologyThe Jackson LaboratoryImmunodeficient MouseT-LymphocyteImmune ResponseMultidisciplinaryEnsureCellsLaboratoriesResearch PersonnelResponseInduced Pluripotent Stem CellInterestCytokineTransplantation
Grant awards (33)
Models to study the synergy between autoimmunity and metabolism in T1D$1,208,620
UG3 · FY2025 · DK · contact PI
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population$846,948
R24 · FY2025 · OD · contact PI
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population$881,450
R24 · FY2024 · OD · contact PI
Humanized Mouse Avatars for T1D$425,000
U01 · FY2023 · DK
Humanized Mouse Avatars for T1D$1,005,973
U01 · FY2022 · DK
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$823,750
R24 · FY2022 · OD
Humanized Mouse Avatars for T1D$1,008,786
U01 · FY2021 · DK
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$823,750
R24 · FY2021 · OD
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus$782,684
R01 · FY2021 · AI · contact PI
Live imaging of SARS-CoV-2 infection in novel humanized mice$499,998
R24 · FY2021 · OD
Humanized Mouse Avatars for T1D$1,011,466
U01 · FY2020 · DK
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$823,750
R24 · FY2020 · OD
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus$782,684
R01 · FY2020 · AI · contact PI
Humanized mice for investigating human stem cell-derived microglia in Alzheimers Disease$420,750
R24 · FY2020 · OD
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus$1,212,059
R01 · FY2019 · AI · contact PI
Humanized Mouse Avatars for T1D$1,064,644
U01 · FY2019 · DK
Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice$840,625
R24 · FY2019 · OD
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus$782,684
R01 · FY2018 · AI · contact PI
Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus$799,559
R01 · FY2017 · AI · contact PI
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$725,922
R24 · FY2017 · OD
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$764,128
R24 · FY2016 · OD
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$748,845
R24 · FY2015 · OD
Retrogenic humanized mice for the study of T1D$213,125
R21 · FY2015 · AI
Humanized Mouse Avatars for T1D$4,109,951
UC4 · FY2014 · DK
Development and Validation of Novel NSG Mouse Models for Human Stem Cell Therapy$780,422
R24 · FY2014 · OD
Retrogenic humanized mice for the study of T1D$271,354
R21 · FY2014 · AI
Virology and Technology Core$137,760
P01 · FY2014 · AI · contact PI
Virology and Technology Core$103,295
P01 · FY2013 · AI · contact PI
Virology and Technology Core$114,574
P01 · FY2012 · AI · contact PI
Virology and Technology Core$181,251
P01 · FY2011 · AI · contact PI
Regulation of Virus-Specific T cell Responses by TNF$205,573
R21 · FY2010 · AI · contact PI
Virology and Technology Core$183,393
P01 · FY2010 · AI · contact PI
Regulation of Virus-Specific T cell Responses by TNF$245,938
R21 · FY2009 · AI · contact PI